Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 371

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1A
Chunk 371
---
 were the first to file for patent protection of such inventions. As a result, the issuance,
scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications
may not result in patents being issued which protect our technology or product candidates, in whole or in part, or which effectively prevent
others from commercializing competitive technologies and product candidates. Changes in either the patent laws or interpretation of the
patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection.

Patent reform legislation in the United States, including the
Leahy-Smith America Invents Act (the “Leahy-Smith Act”), could increase those uncertainties and costs surrounding
the prosecution of our patent applications and the enforcement or defense of our issued patents. The Leahy-Smith Act made significant
changes to U.S. patent law, including the way patent applications are prosecuted, redefined prior art and provided more efficient
and cost-effective avenues for competitors to challenge the validity of patents. The Leahy-Smith Act and its implementation
could increase the uncertainties and costs surrounding the prosecution of our patent applications, our ability to obtain future patents,
and the enforcement or defense of our issued patents, all of which could harm our business, financial condition, results of operations
and prospects.

The issuance of a patent is not conclusive as to its inventorship,
scope, validity or enforceability, and our owned and licensed patents may be challenged in the courts or patent offices in the United States
and abroad.

Any patents that we have or may be issued provide us some protections
but the patent issuance may be challenged on multiple grounds. We may in the future be subject to third-party pre-issuance submissions
of prior art to the USPTO or its equivalents and we or our licensors have in the past, and may in the future, become involved in opposition,
derivation, reexamination, inter partes review, post-grant review or interference proceedings in the U.S. or
in other jurisdictions challenging our patent rights or the patent rights of others. A third party may also claim that our owned or licensed
patent rights are invalid or unenforceable in a litigation.

The outcome following legal assertions of invalidity and unenforceability
is unpredictable. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate,
our